Episode Details
Back to Episodes
FDA Approves First Alzheimer’s Drug in Decades
Published 1 day, 4 hours ago
Description
FDA just approved Lecanemab, the first drug to slow Alzheimer’s progression by targeting amyloid plaques—showing a 27% reduction in decline over 18 months for early-stage patients. It’s not a cure, but it offers real hope—and serious caution—with potential side effects like brain swelling requiring close monitoring.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/bb0a0c60716bca7a